176 related articles for article (PubMed ID: 21052795)
1. Heparin-functionalized collagen matrices with controlled release of basic fibroblast growth factor.
Wu JM; Xu YY; Li ZH; Yuan XY; Wang PF; Zhang XZ; Liu YQ; Guan J; Guo Y; Li RX; Zhang H
J Mater Sci Mater Med; 2011 Jan; 22(1):107-14. PubMed ID: 21052795
[TBL] [Abstract][Full Text] [Related]
2. Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices.
Wissink MJ; Beernink R; Poot AA; Engbers GH; Beugeling T; van Aken WG; Feijen J
J Control Release; 2000 Feb; 64(1-3):103-14. PubMed ID: 10640649
[TBL] [Abstract][Full Text] [Related]
3. Binding and release of basic fibroblast growth factor from heparinized collagen matrices.
Wissink MJ; Beernink R; Pieper JS; Poot AA; Engbers GH; Beugeling T; van Aken WG; Feijen J
Biomaterials; 2001 Aug; 22(16):2291-9. PubMed ID: 11456069
[TBL] [Abstract][Full Text] [Related]
4. Heparin-modified dendrimer cross-linked collagen matrices for the delivery of basic fibroblast growth factor (FGF-2).
Princz MA; Sheardown H
J Biomater Sci Polym Ed; 2008; 19(9):1201-18. PubMed ID: 18727861
[TBL] [Abstract][Full Text] [Related]
5. Endothelial cell seeding of (heparinized) collagen matrices: effects of bFGF pre-loading on proliferation (after low density seeding) and pro-coagulant factors.
Wissink MJ; Beernink R; Scharenborg NM; Poot AA; Engbers GH; Beugeling T; van Aken WG; Feijen J
J Control Release; 2000 Jul; 67(2-3):141-55. PubMed ID: 10825549
[TBL] [Abstract][Full Text] [Related]
6. Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects.
Pieper JS; Hafmans T; Veerkamp JH; van Kuppevelt TH
Biomaterials; 2000 Mar; 21(6):581-93. PubMed ID: 10701459
[TBL] [Abstract][Full Text] [Related]
7. Heparin-functionalized chitosan-alginate scaffolds for controlled release of growth factor.
Ho YC; Mi FL; Sung HW; Kuo PL
Int J Pharm; 2009 Jul; 376(1-2):69-75. PubMed ID: 19450670
[TBL] [Abstract][Full Text] [Related]
8. Collagen/Heparin Bi-Affinity Multilayer Modified Collagen Scaffolds for Controlled bFGF Release to Improve Angiogenesis In Vivo.
Hao W; Han J; Chu Y; Huang L; Zhuang Y; Sun J; Li X; Zhao Y; Chen Y; Dai J
Macromol Biosci; 2018 Nov; 18(11):e1800086. PubMed ID: 30160040
[TBL] [Abstract][Full Text] [Related]
9. Heparin-immobilized biodegradable scaffolds for local and sustained release of angiogenic growth factor.
Yoon JJ; Chung HJ; Lee HJ; Park TG
J Biomed Mater Res A; 2006 Dec; 79(4):934-42. PubMed ID: 16941589
[TBL] [Abstract][Full Text] [Related]
10. In vivo biocompatibility of carbodiimide-crosslinked collagen matrices: Effects of crosslink density, heparin immobilization, and bFGF loading.
van Wachem PB; Plantinga JA; Wissink MJ; Beernink R; Poot AA; Engbers GH; Beugeling T; van Aken WG; Feijen J; van Luyn MJ
J Biomed Mater Res; 2001 Jun; 55(3):368-78. PubMed ID: 11255190
[TBL] [Abstract][Full Text] [Related]
11. Biodegradable elastomeric scaffolds with basic fibroblast growth factor release.
Guan J; Stankus JJ; Wagner WR
J Control Release; 2007 Jul; 120(1-2):70-8. PubMed ID: 17509717
[TBL] [Abstract][Full Text] [Related]
12. Heparinized hydroxyapatite/collagen three-dimensional scaffolds for tissue engineering.
Teixeira S; Yang L; Dijkstra PJ; Ferraz MP; Monteiro FJ
J Mater Sci Mater Med; 2010 Aug; 21(8):2385-92. PubMed ID: 20596760
[TBL] [Abstract][Full Text] [Related]
13. Modulation of angiogenic potential of collagen matrices by covalent incorporation of heparin and loading with vascular endothelial growth factor.
Steffens GC; Yao C; Prével P; Markowicz M; Schenck P; Noah EM; Pallua N
Tissue Eng; 2004; 10(9-10):1502-9. PubMed ID: 15588409
[TBL] [Abstract][Full Text] [Related]
14. Fabrication of chondroitin sulfate-chitosan composite artificial extracellular matrix for stabilization of fibroblast growth factor.
Mi FL; Shyu SS; Peng CK; Wu YB; Sung HW; Wang PS; Huang CC
J Biomed Mater Res A; 2006 Jan; 76(1):1-15. PubMed ID: 16224775
[TBL] [Abstract][Full Text] [Related]
15. Influence of modified extracellular matrices on TI6AL4V implants on binding and release of VEGF.
Wolf-Brandstetter C; Lode A; Hanke T; Scharnweber D; Worch H
J Biomed Mater Res A; 2006 Dec; 79(4):882-94. PubMed ID: 16941591
[TBL] [Abstract][Full Text] [Related]
16. Cell-instructive starPEG-heparin-collagen composite matrices.
Binner M; Bray LJ; Friedrichs J; Freudenberg U; Tsurkan MV; Werner C
Acta Biomater; 2017 Apr; 53():70-80. PubMed ID: 28216298
[TBL] [Abstract][Full Text] [Related]
17. Heparin-conjugated collagen as a potent growth factor-localizing and stabilizing scaffold for regenerative medicine.
Ikegami Y; Mizumachi H; Yoshida K; Ijima H
Regen Ther; 2020 Dec; 15():236-242. PubMed ID: 33426224
[TBL] [Abstract][Full Text] [Related]
18. Sustained release and activation of the growth factor basic fibroblast growth factor from loaded scaffolds in heart valve tissue engineering.
Somers P; Narine K; De Somer F; de Vos F; V Nooten G
Growth Factors; 2008 Oct; 26(5):293-9. PubMed ID: 18651289
[TBL] [Abstract][Full Text] [Related]
19. Gelatin/chitosan/hyaluronan ternary complex scaffold containing basic fibroblast growth factor for cartilage tissue engineering.
Tan H; Gong Y; Lao L; Mao Z; Gao C
J Mater Sci Mater Med; 2007 Oct; 18(10):1961-8. PubMed ID: 17554603
[TBL] [Abstract][Full Text] [Related]
20. Immobilization of heparin to EDC/NHS-crosslinked collagen. Characterization and in vitro evaluation.
Wissink MJ; Beernink R; Pieper JS; Poot AA; Engbers GH; Beugeling T; van Aken WG; Feijen J
Biomaterials; 2001 Jan; 22(2):151-63. PubMed ID: 11101159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
